Corline Biomedical (CLBIO.ST) Stock Price

Corline Biomedical Price

OMX·CLOSED
14.20
​
Market closed

Over the last 13 years Corline Biomedical grew revenue by 1.9% annually, reaching 7.65 M SEK. For Corline Biomedical, the net margin of -192.3% is down versus -97.9% a few years ago.

Corline Biomedical stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corline Biomedical business model & stock analysis

Corline Biomedical AB, headquartered in Uppsala, Sweden, operates in the Health Care sector, specifically within Pharmaceuticals. The company focuses on the research, development, and commercialization of heparin-based solutions for kidney transplantation, cell therapies, and regenerative medicine applications. Listed on 3 June 2015, Corline Biomedical employs eight people and is dedicated to advancing medical treatments through innovative heparin-based technologies.

Frequently asked questions about Corline Biomedical

Converted at the current exchange rate, the Corline Biomedical share trades at 1.28 EUR (14.20 SEK).

The Corline Biomedical share (CLBIO.ST) is listed on 2 stock exchanges, including: Stockholm (CLBIO.ST).

The expected revenue of Corline Biomedical is 16.40 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Corline Biomedical is 17.93 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Corline Biomedical is currently 20.17. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Corline Biomedical stock.

The price-to-sales ratio (P/S) of Corline Biomedical is currently 22.05. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Corline Biomedical stock.

The Eulerpool Quality Score for Corline Biomedical is 4/10.

The ISIN of Corline Biomedical is SE0006887451. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Corline Biomedical is CLBIO.ST. The ticker symbol is used to trade Corline Biomedical shares on the stock exchange.

Fair ValueTerminal
11.93 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
956,375.00 SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website corline.se
Country
Sweden
Currency
SEK
Initial public offering
Jun 3, 2015
ISIN
SE0006887451
Cusip
W2R205106
Market capitalization
363.66 M SEKSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
20.29
P/Ee 2027
11.83
P/Ee 2028
—
P/Se
22.05
EV/EBIT
—
P/B Ratio
3.88
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-15.69 %
Last updated Nov 16, 2026, 3:46 AM

Corline Biomedical Peer Group

Corline Biomedical Ticker

STOCKHOLM · CLBIO.STSTOCKHOLM · CLBIO.ST

Corline Biomedical FIGI

CLBIO:SF · BBG009BHZN38CLBIOSEK:EO · BBG009BS9DY1CLBIOSEK:XH · BBG009BS9F12CLBIOSEK:XF · BBG009BS9F30CLBIOSEK:XE · BBG009BS9F58CLBIOSEK:XJ · BBG009BS9F67CLBIOSEK:XL · BBG009BS9F76CLBIOSEK:XG · BBG009BS9F85CLBIOSEK:XO · BBG009BS9F94CLBIOSEK:XS · BBG009BS9FF7CLBIOSEK:XA · BBG009BS9FG6CLBIOSEK:E1 · BBG009BS9FH5